603127 昭衍新药
已收盘 09-03 15:00:00
资讯
新帖
简况
昭衍新药（603127）披露8月证券变动月报表，9月2日股价下跌1.28%
证券之星 · 09-02 22:10
昭衍新药（603127）披露8月证券变动月报表，9月2日股价下跌1.28%
昭衍新药（603127）2026年中报简析：营收净利润同比双双增长
证券之星 · 08-30
昭衍新药（603127）2026年中报简析：营收净利润同比双双增长
每周股票复盘：昭衍新药（603127）Q2净利同比增2469.84%
证券之星 · 08-30
每周股票复盘：昭衍新药（603127）Q2净利同比增2469.84%
昭衍新药（603127）披露召开2026年半年度业绩说明会公告，8月28日股价下跌1.25%
证券之星 · 08-28
昭衍新药（603127）披露召开2026年半年度业绩说明会公告，8月28日股价下跌1.25%
昭衍新药(06127)公布中期业绩 股东应占溢利约7.48亿元 同比增长约11.27倍
智通财经 · 08-28
昭衍新药(06127)公布中期业绩 股东应占溢利约7.48亿元 同比增长约11.27倍
昭衍新药：上半财年净利润同比增长1126.8%
南方财经网 · 08-28
昭衍新药：上半财年净利润同比增长1126.8%
昭衍新药：2026年上半年净利7.48亿元 同比增1126.8%
格隆汇 · 08-28
昭衍新药：2026年上半年净利7.48亿元 同比增1126.8%
8月24日昭衍新药跌5.85%，广发医疗保健股票A基金重仓该股
证券之星 · 08-24
8月24日昭衍新药跌5.85%，广发医疗保健股票A基金重仓该股
每周股票复盘：昭衍新药（603127）将发布中期业绩
证券之星 · 08-23
每周股票复盘：昭衍新药（603127）将发布中期业绩
昭衍新药（603127）披露与专业投资机构合作参与投资基金的进展公告，8月20日股价上涨5.56%
证券之星 · 08-20
昭衍新药（603127）披露与专业投资机构合作参与投资基金的进展公告，8月20日股价上涨5.56%
8月19日昭衍新药跌7.61%，广发医疗保健股票A基金重仓该股
证券之星 · 08-19
8月19日昭衍新药跌7.61%，广发医疗保健股票A基金重仓该股
昭衍新药（603127）披露董事会会议安排，8月18日股价上涨0.79%
证券之星 · 08-18
昭衍新药（603127）披露董事会会议安排，8月18日股价上涨0.79%
昭衍新药：低价订单正在有序出清
证券之星 · 08-12
昭衍新药：低价订单正在有序出清
昭衍新药：截至2026年一季度末在手订单金额为31亿元人民币
证券之星 · 08-12
昭衍新药：截至2026年一季度末在手订单金额为31亿元人民币
每周股票复盘：昭衍新药（603127）A股限制性股票激励计划完成授予
证券之星 · 08-09
每周股票复盘：昭衍新药（603127）A股限制性股票激励计划完成授予
8月7日昭衍新药涨10.01%，广发医疗保健股票A基金重仓该股
证券之星 · 08-07
8月7日昭衍新药涨10.01%，广发医疗保健股票A基金重仓该股
港股异动 | 昭衍新药(06127)涨超11% 公司上半年业绩大幅预增 生物资产公允价值正向变动成为核心驱动力
智通财经 · 08-07
港股异动 | 昭衍新药(06127)涨超11% 公司上半年业绩大幅预增 生物资产公允价值正向变动成为核心驱动力
异动快报：昭衍新药（603127）8月7日14点7分触及涨停板
证券之星 · 08-07
异动快报：昭衍新药（603127）8月7日14点7分触及涨停板
昭衍新药（603127）披露2026年A股限制性股票激励计划授予完成情况，8月5日股价上涨4.4%
证券之星 · 08-05
昭衍新药（603127）披露2026年A股限制性股票激励计划授予完成情况，8月5日股价上涨4.4%
8月4日昭衍新药涨8.04%，广发医疗保健股票A基金重仓该股
证券之星 · 08-04
8月4日昭衍新药涨8.04%，广发医疗保健股票A基金重仓该股
加载更多
公司概况
公司名称：
北京昭衍新药研究中心股份有限公司
所属行业：
研究和试验发展
上市日期：
2017-08-25
主营业务：
北京昭衍新药研究中心股份有限公司的主营业务是提供药物非临床研究服务。公司的主要产品是非临床评价服务和药物发现服务、临床试验全流程服务、专业临床检测服务、实验模型研究。
发行价格：
12.51
{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":44.6,"timestamp":1788418800000,"preClose":44.6,"halted":0,"volume":26198015,"delay":0,"changeRate":0,"floatShares":628000000,"shares":749000000,"eps":1.3138,"marketStatus":"已收盘","change":0,"latestTime":"09-03 15:00:00","open":44.88,"high":44.99,"low":43.76,"amount":1162000000,"amplitude":0.0276,"askPrice":44.61,"askSize":49,"bidPrice":44.6,"bidSize":1273,"shortable":0,"etf":0,"ttmEps":1.3138,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":5,"adr":0,"adjPreClose":44.6,"symbolType":"stock","openAndCloseTimeList":[[1788399000000,1788406200000],[1788411600000,1788418800000]],"highLimit":49.06,"lowLimit":40.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749348220,"isCdr":false,"pbRate":3.72,"roa":"--","peRate":33.947328,"roe":"8.61%","epsLYR":0.4,"committee":0.729238,"marketValue":33421000000,"turnoverRate":0.0417,"status":2,"hkstockBrief":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":23.62,"timestamp":1788422901005,"preClose":23,"halted":0,"volume":2598449,"delay":0,"premium":"-54.62"},"floatMarketCap":27996000000},"requestUrl":"/m/hq/s/603127","defaultTab":"news","newsList":[{"id":"2664681762","title":"昭衍新药（603127）披露8月证券变动月报表，9月2日股价下跌1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664681762","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664681762?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:10","pubTimestamp":1788358228,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，昭衍新药报收于44.6元，较前一交易日下跌1.28%，最新总市值为334.21亿元。该股当日开盘45.18元，最高45.66元，最低44.03元，成交额达12.86亿元，换手率为4.58%。近日，公司发布H股公告《8月月报表》。公司确认2026年8月无股份增减，公众持股量符合上市规则要求，且所有证券发行事项均已获董事会批准并遵守相关法规。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK0216","06127","BK1141","161027","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048925","title":"昭衍新药（603127）2026年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048925?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:11","pubTimestamp":1788041472,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期昭衍新药发布2026年中报。根据财报显示，昭衍新药营收净利润同比双双增长。截至本报告期末，公司营业总收入7.04亿元，同比上升5.27%，归母净利润7.48亿元，同比上升1126.8%。本文数据来源于昭衍新药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010890","title":"每周股票复盘：昭衍新药（603127）Q2净利同比增2469.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010890","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010890?lang=zh_cn&edition=full","pubTime":"2026-08-30 01:26","pubTimestamp":1788024370,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，昭衍新药报收于47.54元，较上周的49.27元下跌3.51%。本周关注点业绩披露要点：2026年第二季度归母净利润5.09亿元，同比上升2469.84%。业绩披露要点昭衍新药2026年中报显示，上半年度公司主营收入7.04亿元，同比上升5.27%；归母净利润7.48亿元，同比上升1126.8%；扣非净利润6.99亿元，同比上升2931.69%。第二季度单季度主营收入3.88亿元，同比上升1.69%；单季度归母净利润5.09亿元，同比上升2469.84%；单季度扣非净利润4.81亿元，同比上升18544.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK0216","BK1576","BK1141","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662833099","title":"昭衍新药（603127）披露召开2026年半年度业绩说明会公告，8月28日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662833099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662833099?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:02","pubTimestamp":1787925731,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，昭衍新药报收于47.54元，较前一交易日下跌1.25%，最新总市值为356.24亿元。该股当日开盘48.0元，最高51.51元，最低47.5元，成交额达18亿元，换手率为5.88%。公司将于2026年9月8日9:00-10:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司半年度经营成果及财务状况。投资者可于2026年9月1日至9月7日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过该平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800053403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","BK0216","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066223","title":"昭衍新药(06127)公布中期业绩 股东应占溢利约7.48亿元 同比增长约11.27倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066223","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066223?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:54","pubTimestamp":1787910886,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)公布2026年中期业绩，收益约7.04亿元，同比增长5.3%;公司权益股东应占期内溢利约7.48亿元，同比增长约11.27倍;每股盈利1元。报告期内，公司整体在手订单金额约为37亿元，同比增长60.9%;新签订单金额约为20.2亿元，同比增长98.0%。公告称，净利润增加主要是由于生物资产公平值变动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","06127","BK0216","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662306602","title":"昭衍新药：上半财年净利润同比增长1126.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662306602","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662306602?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:43","pubTimestamp":1787910180,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电，昭衍新药（06127.HK）公告，公司截至2026年6月30日止六个月实现营业收入70381.90万元，同比增长5.27%；净利润74750.00万元，同比增长1126.8%；基本及摊薄每股收益均为1.00元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283858311650.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283858311650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662806816","title":"昭衍新药：2026年上半年净利7.48亿元 同比增1126.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662806816","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662806816?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:55","pubTimestamp":1787907355,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1141","BK0216","BK1576","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661622126","title":"8月24日昭衍新药跌5.85%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661622126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661622126?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:31","pubTimestamp":1787560265,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日昭衍新药跌5.85%，收盘报46.39元，换手率5.86%，成交量36.79万手，成交额17.38亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值1.9538，较上一交易日下跌3.58%，近一年下跌6.23%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","BK1576","603127","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661321132","title":"每周股票复盘：昭衍新药（603127）将发布中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2661321132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661321132?lang=zh_cn&edition=full","pubTime":"2026-08-23 01:05","pubTimestamp":1787418313,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，昭衍新药报收于49.27元，较上周的51.3元下跌3.96%。本周，昭衍新药8月20日盘中最高价报54.78元。公司公告汇总H股公告：董事会召开日期北京昭衍新药研究中心股份有限公司董事会谨定于2026年8月28日举行董事会会议，以考虑及通过本集团截至2026年6月30日止六个月中期业绩，并处理其他事项。本次会议由董事会主席冯宇霞召集，于2026年8月18日在中国北京发布公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","603127","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660801992","title":"昭衍新药（603127）披露与专业投资机构合作参与投资基金的进展公告，8月20日股价上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660801992","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660801992?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:00","pubTimestamp":1787234456,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，昭衍新药报收于52.57元，较前一交易日上涨5.56%，最新总市值为393.93亿元。该股当日开盘52.0元，最高54.78元，最低49.5元，成交额达36.9亿元，换手率为11.22%。上述基金已完成中国证券投资基金业协会的备案登记。公司将持续关注基金运作情况并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000044559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127","BK1141","BK0216","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660459054","title":"8月19日昭衍新药跌7.61%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660459054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660459054?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:34","pubTimestamp":1787128495,"startTime":"0","endTime":"0","summary":"证券之星消息，8月19日昭衍新药跌7.61%，收盘报49.8元，换手率7.38%，成交量46.31万手，成交额23.77亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值2.0097，较上一交易日下跌0.43%，近一年下跌4.59%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900028155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK0216","BK1141","BK1576","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660498251","title":"昭衍新药（603127）披露董事会会议安排，8月18日股价上涨0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660498251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660498251?lang=zh_cn&edition=full","pubTime":"2026-08-18 22:08","pubTimestamp":1787062101,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，昭衍新药报收于53.9元，较前一交易日上涨0.79%，最新总市值为403.9亿元。该股当日开盘53.08元，最高54.53元，最低52.8元，成交额达21.63亿元，换手率为6.43%。近日，公司发布H股公告披露，董事会谨定于2026年8月28日举行董事会会议，以考虑及通过本集团截至2026年6月30日止六个月中期业绩，并处理其他事项。本次会议由董事会主席冯宇霞召集，公告发布日期为2026年8月18日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800042260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1141","BK1576","603127","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658753589","title":"昭衍新药：低价订单正在有序出清","url":"https://stock-news.laohu8.com/highlight/detail?id=2658753589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658753589?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:39","pubTimestamp":1786527545,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药08月12日在投资者关系平台上答复投资者关心的问题。低价订单方面，自 2025 年四季度行业回暖、新单量价修复以来，前期存量低价订单正在有序出清。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200030931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","06127","603127","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978431","title":"昭衍新药：截至2026年一季度末在手订单金额为31亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658978431?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:57","pubTimestamp":1786525037,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药(603127)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问贵公司在手订单、项目排期情况如何？实验动物相关价格和订单如何？昭衍新药回复：您好！截至 2026 年一季度末，公司在手订单金额为 31 亿元人民币。伴随生物医药行业需求企稳回暖，现有订单形成一定的交付排期，叠加行业景气度修复，非人灵长类实验动物价格和订单签约价格相较前期都有所回升。感谢关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200028146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","CYB","CNHmain","UCmain","MCNHmain","BK0216","603127","06127","BK1576","MUCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658735466","title":"每周股票复盘：昭衍新药（603127）A股限制性股票激励计划完成授予","url":"https://stock-news.laohu8.com/highlight/detail?id=2658735466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658735466?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:05","pubTimestamp":1786208712,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，昭衍新药报收于50.89元，较上周的41.54元上涨22.51%。本周关注点公司公告汇总：2026年A股限制性股票激励计划于7月22日完成授予，A股已发行股份增加2,636,300股。公司公告汇总H股公告：7月月报表北京昭衍新药研究中心股份有限公司截至2026年7月31日的证券变动月报表显示，H股和A股的法定注册资本无变动。本月底已发行A股总数为630,353,014股，其中库存股为537,620股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","BK1576","BK1141","603127","159982","BK0216","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657961579","title":"8月7日昭衍新药涨10.01%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657961579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657961579?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:37","pubTimestamp":1786091852,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日昭衍新药涨10.01%，收盘报50.89元，换手率9.48%，成交量59.53万手，成交额28.88亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值1.8412，较上一交易日下跌0.3%，近一年下跌11.34%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700027893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","06127","603127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657818618","title":"港股异动 | 昭衍新药(06127)涨超11% 公司上半年业绩大幅预增 生物资产公允价值正向变动成为核心驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2657818618","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657818618?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:20","pubTimestamp":1786087248,"startTime":"0","endTime":"0","summary":"消息面上，近期，昭衍新药发布2026半年度业绩预告，中邮证券指出，2026年上半年，公司预计实现营业收入约6.69亿元至7.39亿元，实现归母净利润约6.00亿元至9.00亿元，实现扣非归母净利润约5.61亿元至8.42亿元。中邮证券认为，生物资产公允价值正向变动成为昭衍新药本期业绩爆发的核心驱动力。2026H1公司生物资产公允价值变动贡献的净利润约7.03亿元至7.77亿元，较2025年同期的0.88亿元大幅提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","VXUS","BK4588","BK4585","06127","BK1141","603127","BK0216","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657589694","title":"异动快报：昭衍新药（603127）8月7日14点7分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2657589694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657589694?lang=zh_cn&edition=full","pubTime":"2026-08-07 14:10","pubTimestamp":1786083046,"startTime":"0","endTime":"0","summary":"证券之星8月7日盘中消息，14点7分昭衍新药（603127）触及涨停板。其所属行业医疗服务目前上涨。领涨股为博腾股份。该股为基因编辑，CAR-T疗法，创新药概念热股，当日基因编辑概念上涨6.16%，CAR-T疗法概念上涨5.68%，创新药概念上涨5.52%。8月6日的资金流向数据方面，主力资金净流入4704.0万元，占总成交额2.34%，游资资金净流出8636.49万元，占总成交额4.29%，散户资金净流入3932.48万元，占总成交额1.95%。近5日资金流向一览见下表：昭衍新药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700020312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK0216","BK1141","BK1576","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657281645","title":"昭衍新药（603127）披露2026年A股限制性股票激励计划授予完成情况，8月5日股价上涨4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657281645","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657281645?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:04","pubTimestamp":1785938665,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，昭衍新药报收于46.3元，较前一交易日上涨4.4%，最新总市值为346.95亿元。近日，公司披露H股公告《7月月报表》。公告显示，北京昭衍新药研究中心股份有限公司截至2026年7月31日的证券变动月报表显示，H股和A股的法定注册资本无变动。A股已发行股份因2026年A股限制性股票激励计划于2026年7月22日授予，导致已发行股份增加2,636,300股，库存股相应减少2,636,300股。本月底已发行A股总数为630,353,014股，其中库存股为537,620股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","603127","399300","06127","BK1576","159982","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656365725","title":"8月4日昭衍新药涨8.04%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656365725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656365725?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:35","pubTimestamp":1785832545,"startTime":"0","endTime":"0","summary":"证券之星消息，8月4日昭衍新药涨8.04%，收盘报44.35元，换手率9.81%，成交量61.56万手，成交额26.96亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值1.7486，较上一交易日下跌2.18%，近一年下跌16.94%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1576","BK0216","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788464225616,"stockEarnings":[{"period":"1week","weight":-0.0735},{"period":"1month","weight":0.0056},{"period":"3month","weight":0.3722},{"period":"6month","weight":0.341},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.2778}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0313},{"period":"3month","weight":-0.0213},{"period":"6month","weight":-0.0442},{"period":"1year","weight":0.0337},{"period":"ytd","weight":-0.0067}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","registeredCapital":"74934万元","survey":" 北京昭衍新药研究中心股份有限公司的主营业务是提供药物非临床研究服务。公司的主要产品是非临床评价服务和药物发现服务、临床试验全流程服务、专业临床检测服务、实验模型研究。","listedPrice":12.51},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,603127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}